American International Group, Inc. Satsuma Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.8 - $7.25 $25,713 - $38,838	-5,357 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.57 - $7.18 $63 - $100	14 Added 0.26%	5,357 $32,000
Q4 2020 Feb 12, 2021	SELL	$3.56 - $5.09 $544 - $778	-153 Reduced 2.78%	5,343 $25,000
Q3 2020 Nov 04, 2020	SELL	$3.85 - $28.47 $485 - $3,587	-126 Reduced 2.24%	5,496 $21,000
Q2 2020 Aug 12, 2020	BUY	$16.01 - $34.69 $47,645 - $103,237	2,976 Added 112.47%	5,622 $162,000
Q1 2020 May 04, 2020	SELL	$14.53 - $30.69 $1,801 - $3,805	-124 Reduced 4.48%	2,646 $57,000
Q4 2019 Feb 05, 2020	BUY	$9.32 - $19.68 $25,816 - $54,513	2,770 New	2,770 $55,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.